Literature DB >> 23649317

Serial evaluation of hepatic function profile after Fontan operation.

R Kaulitz1, P Haber, E Sturm, J Schäfer, M Hofbeck.   

Abstract

Moderate persistent elevation of the γ-glutamyltransferase (γGT) level is a frequent finding during long-term follow-up of patients with total cavopulmonary connection (TCPC) for palliation of functionally univentricular hearts. Serial intraindividual data revealed a significant increase in the γGT level within a minimum 4-year interval in more than 80 % of cases. The level of γGT elevation showed a significant correlation to hemodynamic parameters such as systemic ventricular end diastolic pressure and mean pulmonary artery pressure, but did not strongly correlate with duration of follow-up or other liver function parameters, which were less frequent and less impressively deranged. None of the patients had signs of synthetic dysfunction. With increasing postoperative follow-up, abnormalities of sonographic hepatic texture including increased echogenicity, inhomogeneity, or liver surface nodularity were found. All 17 patients with liver surface nodularity had a follow-up period of over 10 years. Structural abnormalities did not correlate with biochemical or hemodynamic parameters. Doppler evaluation revealed inspiratory dependence of hepatic vein flow in more than 90 % as a relevant finding after TCPC; a decrease in portal vein flow velocity was observed in many patients. Since long-term survivors after Fontan procedure are at an increased risk of cardiac hepatopathy and cirrhosis, detailed routine investigation and monitoring of hepatic morphology are needed.

Entities:  

Mesh:

Year:  2013        PMID: 23649317     DOI: 10.1007/s00059-013-3811-5

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  23 in total

Review 1.  The Fontan procedure: analysis of cohorts and late complications.

Authors:  R M Freedom; R Hamilton; S J Yoo; H Mikailian; L Benson; B McCrindle; H Justino; W G Williams
Journal:  Cardiol Young       Date:  2000-10       Impact factor: 1.093

2.  Sequelae after modified Fontan operation: postoperative haemodynamic data and organ function.

Authors:  R Kaulitz; I Luhmer; F Bergmann; B Rodeck; G Hausdorf
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

Review 3.  Liver disease in the patient with Fontan circulation.

Authors:  Fred M Wu; Chinweike Ukomadu; Robert D Odze; Anne Marie Valente; John E Mayer; Michael G Earing
Journal:  Congenit Heart Dis       Date:  2011-03-28       Impact factor: 2.007

4.  Long-term results of the lateral tunnel Fontan operation.

Authors:  C Stamm; I Friehs; J E Mayer; D Zurakowski; J K Triedman; A M Moran; E P Walsh; J E Lock; R A Jonas
Journal:  J Thorac Cardiovasc Surg       Date:  2001-01       Impact factor: 5.209

5.  Non-invasive assessment of liver fibrosis in patients after the Fontan operation.

Authors:  Takeshi Furukawa; Katsumi Akimoto; Masahiro Ohtsuki; Keiko Sato; Mitsuyoshi Suzuki; Ken Takahashi; Masahiko Kishiro; Toshiaki Shimizu; Shiori Kawasaki
Journal:  Pediatr Int       Date:  2011-12       Impact factor: 1.524

6.  Portal and sinusoidal fibrosis are common on liver biopsy after Fontan surgery.

Authors:  Matthew C Schwartz; Lisa M Sullivan; Andrew C Glatz; Elizabeth Rand; Pierre Russo; David J Goldberg; Jonathan J Rome; Meryl S Cohen
Journal:  Pediatr Cardiol       Date:  2012-06-14       Impact factor: 1.655

7.  Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial.

Authors:  Andrew P Ambrosy; Muthiah Vaduganathan; Mark D Huffman; Sadiya Khan; Mary J Kwasny; Angela J Fought; Aldo P Maggioni; Karl Swedberg; Marvin A Konstam; Faiez Zannad; Mihai Gheorghiade
Journal:  Eur J Heart Fail       Date:  2012-03       Impact factor: 15.534

8.  Hepatic dysfunction following the Fontan procedure.

Authors:  Michael R Narkewicz; Henry M Sondheimer; James W Ziegler; Yvonne Otanni; Angela Lorts; Elizabeth M Shaffer; J Gerard Horgan; Ronald J Sokol
Journal:  J Pediatr Gastroenterol Nutr       Date:  2003-03       Impact factor: 2.839

9.  Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers.

Authors:  Mireen Friedrich-Rust; Constanze Koch; Axel Rentzsch; Christoph Sarrazin; Peter Schwarz; Eva Herrmann; Angelika Lindinger; Ulrike Sarrazin; Thierry Poynard; Hans-Joachim Schäfers; Stefan Zeuzem; Hashim Abdul-Khaliq
Journal:  J Thorac Cardiovasc Surg       Date:  2008-03       Impact factor: 5.209

Review 10.  The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium.

Authors:  Jack Rychik; Gruschen Veldtman; Elizabeth Rand; Pierre Russo; Jonathan J Rome; Karen Krok; David J Goldberg; Anne Marie Cahill; Rebecca G Wells
Journal:  Pediatr Cardiol       Date:  2012-04-26       Impact factor: 1.655

View more
  9 in total

Review 1.  Congestive hepatopathy: Differentiating congestion from fibrosis.

Authors:  Alexander Lemmer; Lisa VanWagner; Daniel Ganger
Journal:  Clin Liver Dis (Hoboken)       Date:  2018-01-02

Review 2.  MR assessment of abdominal circulation in Fontan physiology.

Authors:  Shi-Joon Yoo; Milan Prsa; Daryl Schantz; Lars Grosse-Wortmann; Mike Seed; Tae Kyoung Kim; Rachel Wald; Rajiv Chaturvedi
Journal:  Int J Cardiovasc Imaging       Date:  2014-04-22       Impact factor: 2.357

Review 3.  Assessment of Advanced Liver Fibrosis and the Risk for Hepatic Decompensation in Patients With Congestive Hepatopathy.

Authors:  Alexander Lemmer; Lisa B VanWagner; Daniel Ganger
Journal:  Hepatology       Date:  2018-09-22       Impact factor: 17.425

Review 4.  Screening modalities for the diagnosis of Fontan-associated liver disease: evidence from the past for future development.

Authors:  Saviga Sethasathien; Krit Leemasawat; Suchaya Silvilairat; Rekwan Sittiwangkul; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

5.  Hepatic Changes in the Fontan Circulation: Identification of Liver Dysfunction and an Attempt to Streamline Follow-up Screening.

Authors:  T Ackerman; A Geerts; H Van Vlierberghe; J De Backer; K François
Journal:  Pediatr Cardiol       Date:  2018-07-21       Impact factor: 1.655

6.  Fontan Liver Disease: Review of an Emerging Epidemic and Management Options.

Authors:  Elisa Bradley; Benjamin Hendrickson; Curt Daniels
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-11

7.  Serum hyaluronic acid concentration in Fontan circulation: correlation with hepatic function and portal vein hemodynamics.

Authors:  Taiyu Hayashi; Ryo Inuzuka; Takahiro Shindo; Yoichiro Hirata; Nobutaka Shimizu; Akira Oka
Journal:  Pediatr Cardiol       Date:  2013-10-26       Impact factor: 1.655

8.  Non-cardiac comorbidities in adults with inherited and congenital heart disease: report from a single center experience of more than 800 consecutive patients.

Authors:  Rhoia Clara Neidenbach; Eckart Lummert; Matthias Vigl; Reinhard Zachoval; Michael Fischereder; Andrea Engelhardt; Claudia Pujol; Renate Oberhoffer; Nicole Nagdyman; Peter Ewert; Michael Hauser; Harald Kaemmerer
Journal:  Cardiovasc Diagn Ther       Date:  2018-08

9.  Impact of liver fibrosis and nodules formation on hemodynamics in young adults after total cavopulmonary connection. A magnetic resonance study.

Authors:  Václav Chaloupecký; Denisa Jičínská; Viktor Tomek; Ondřej Materna; Roman Gebauer; Rudolf Poruban; Petra Antonová; Theodor Adla; Matěj Štefánek; Vojtěch Illinger; Karel Kotaška; Jan Janoušek
Journal:  Front Cardiovasc Med       Date:  2022-09-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.